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INTRODUCTION
The three major causes of maternal mortality in
Indonesia are bleeding (30%), eclampsia (25%)
and infection (12%). The World Health Organiza-
tion (WHO) estimated that the rate of preeclampsia
were seven times higher in developing countries
compared to developed countries. The prevalence
of preeclampsia in developed countries ranges
from 1.3% to 6%, while in developing countries
from 1.8% to 18%. The incidence of preeclampsia
in Indonesia is 128 273 per year, or 5.3%.1
During the last 8 years (from 2005 to 2013), the
incidence of severe preeclampsia tends to increase
at Dr. Wahidin Sudirohusodo Hospital. The
incidence of severe preeclampsia in 2005-2007 by
8%, rising to 8.6% in the period 2007-2009, then
in 2009-2011 increased by 13.47% and in the
period of 2011-2013 the incidence up to 16.51%.2
Preeclampsia is best described as a special-
pregnancy syndrome involving multiorgan
systems.3,4 In the past, preeclampsia could be
diagnosed whenever we found its clinical triad i.e,
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Abstrak
Tujuan: Mengetahui kadar C-Reactive Protein perempuan hamil
trimester dua yang menjadi preeklamsia dan bukan preeklam-sia, serta mengetahui hubungan antara kadar C-Reactive Pro-
tein kehamilan trimester dua dengan kejadian preeklamsia.
Metode: Penelitian ini menggunakan rancangan kohort prospektif, di-
laksanakan di Poliklinik RS jejaring pendidikan Departemen Obstetri
dan Ginekologi FK UNHAS dan Poliklinik Kesehatan Ibu dan Anak danbeberapa Puskesmas Kota Makassar selama September 2015 - April
2016. Dilakukan pemeriksaan kadar C-Reactive Protein 115 ibu hamilpada usia kehamilan 24 - 28 minggu, kemudian diamati apakah sub-
jek mengalami preeklamsia hingga proses persalinan. Analisis statistik
menggunakan uji Fisher’s exact dan uji Mann Whitney.
Hasil: Didapatkan hasil 9 subjek (7,8%) berkembang menjadi
preeklamsia dan 106 subjek tidak menjadi preeklamsia. Terjadipeningkatan kadar C-Reactive Protein pada kelompok preeklamsia
dibanding kelompok bukan preeklamsia yaitu 5,05  1,153 : 3,36 0,265 tapi hasilnya tidak bermakna secara statistik (nilai p>0,05).
Kesimpulan: Nilai rerata kadar C-Reactive Protein kelompok pre-eklamsia 33,5% lebih tinggi dibandingkan dengan kelompok bukan
preeklamsia, namun hasil ini belum dapat digunakan sebagai nilai
untuk memprediksi kejadian preeklamsia.
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blood pressure  140/90 mmHg, proteinuria and
edema. Currently, edema is no longer be included
in the diagnostic criteria for preeclampsia because
edema was also observed in normal pregnancy.
Proteinuria was defined as urinary protein excre-
tion exceeds 300 mg in 24 hours, the ratio of pro-
tein: urinary creatinine  0.3 or presence of protein
as much as 30 mg / dl (1+) in a random sample of
urine is settled.1,5
The risk factors that have been identified can be
helpful in assessing the risk of pregnancy in early
antenatal visit. There are two parts of risk factors
of preeclampsia, included high risk factors (major
factors) and additional (minor factors). High risk
for preeclampsia is history of preeclampsia in a
previous pregnancy, multiple pregnancy, diseases
that accompany pregnancy (chronic hypertension,
diabetes mellitus, chronic kidney disease and
phospholipid syndrome). Additional risk factors
are the body mass index  35 kg/m2, vascular
diseases, maternal age  40, nullipara ( the first
pregnancy with a new partner or a previous
pregnancy is  10 years), a history of preeclampsia
at her mother or sister, pregnancy with donor
sperm insemination, oocyte or embryo, diastolic
blood pressure  80 mmHg, and proteinuria.1
A study conducted by Rozikhan, in Kendal
Hospital found that the risk factors of severe
preeclampsia were significantly in the presence of
history of preeclampsia (p = 0.001), descent (p =
0.001), the first child parity/ nullipara (p = 0.001).6
To this date, there are various findings of
biomarkers that can be used to predict the
incidence of preeclampsia, but none of these tests
that have high sensitivity and specificity as well as
there is no test filters that are reliable, valid and
economical.3
C-Reactive Protein (CRP), a sensitive marker for
inflammation and tissue damage, can be a potential
marker. Plasma level of CRP increases in cases of
acute infection, malignancy, and inflammatory
diseases. CRP can bind to chromatin, which is
released from necrotic cells or apoptotic cells, and
to a small ribonucleoprotein nucleus particles. This
shows us that the CRP, in the adjustment function,
can play a role in inducing the inflammatory
response that is characteristic of preeclampsia.7
Based on that study, our study want assessed the
relationship levels of C-Reactive Protein in the
second trimester of pregnancy with preeclampsia.
METHODS
This study was conducted at the networking of
Obstetrics and Gynecology Department, Faculty of
Medicine, Universitas Hasanuddin and primary
health centers in the city of Makassar. This study
was designed as a prospective cohort study.
Consecutive sampling by the number of subjects
115 people. Subjects who suited for the criteria
sample of pregnant women at trimester II, then
were informed about how’s the purpose and
objective of the study is worked, and who are
willing to participate the study will sign a consent
form and then examination was performed. After
that we do the questionnaires, included the form
data of anamnesis, physical examination and
laboratory investigation. Blood samples were taken
as much as 3 cc by using a tube serum separator
tube (SST) and then they will be sent to a
laboratory for examination (Prodia Makassar
Laboratory) for measure the levels of C-reactive
protein. Patients were followed monthly their
pregnancy until the labor time. Final data capture
and collect include preeclampsia and time of birth.
Data analysis using Fisher’s Exact test and Mann
Whitney test.
The inclusion criteria of this study were
pregnant women with second trimester of
pregnancy (24-28 weeks) that antenatal and
planned deliveries in the city of Makassar, and
women with a complete personal identity and
has a phone number that can be contacted and
volunteered to followed this study.
Pregnant women with history of metabolic
diseases such as diabetes mellitus, cardiovascular
disease, and coronary heart disease, were
excluded. And if the blood sample lysis, the data
were incomplete or did not follow the entire
procedure, and patients withdrew for certain
reasons.
RESULTS
In this study, we got 115 of the second trimester
pregnant women, with gestational age range 24-28
weeks who were willing to be the subject of study
from the beginning to the end of the study. Of the
115 subjects, obtained 9 (7.8%) of women who
become preeclampsia during the study and serve
as a research group, and 106 people who did not
become preeclampsia used as a control group.
From Table 1 we can see the tendency of
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preeclampsia occurs at age 20-35 years, women
who did not work, and multiparous.
Table 1. Distribution of General Characteristic of the
Samples
Characteristic
Preeclampsia
(n = 9) not Preeclampsia(n = 106)
p
n % n %
Age (years)
< 20 and > 35 2 22.2 28 26.4
0.56920 - 35 7 77.8 78 73.6
Occupation
Employer 3 33.3 15 14.1
0.147Housewife 6 66.7 91 85.9
Parity
Nullipara/
primipara
4 44.4 74 69.8
0.118
Multipara 5 55.6 32 30.2
In Table 2, the data stratified by risk factors of
preeclampsia. Of the 23 subjects who did not have
the risk factors were 2 (8.7%) subjects who
developed into preeclampsia, whereas 92 subjects
with risk factors obtained 7 subjects who
developed into preeclampsia. Between 5 of
preeclampsia risk factors identified in the study
subjects, subjects with risk factors of age over 40
years (16.7%), Nulli / primiparous (5.1%), history
of previous preeclampsia (33.3%), a history of
hypertension in pregnancy in mothers or sisters
(10%), which later developed into preeclampsia,
although not statistically significant (p <0.05).
Table 3 shows the mean value (mean) of
C-Reactive Protein in the preeclampsia group and
non-preeclampsia group. There is no significant
found a relationship between preeclampsia group
and non-preeclampsia group instead in case of
elevated levels of C-Reactive Protein.
Table 3. Correlation between C-Reactive Protein with
Preeclampsia
Preeclampsia
(n = 9) No Preeclampsia(n = 106) p
CRP level 5.05  1.153 3.36  0.265 0.094
In addition, the mean CRP levels in those with
preeclampsia was 33.5%, higher when compared
with the group with not preeclampsia. Figure 1
shows the distribution of CRP levels in the study
subjects. Figure 2 shows the difference in CRP
between groups of preeclampsia and non-
preeclampsia. In the plot of these data, it appears
that CRP levels are not evenly distributed well. It
looks at the median value which is not precisely in
the middle of the box and whisker at the top and
bottom do not have the same length, one of
another has a length more than others. It can be
concluded that CRP levels are not distributed
normally.
Table 2. Characteristic Datas of the Risk Factors of Preeclampsia
Characteristic
Preeclampsia no Preeclampsia
Total p
n % n %
No risk factor 2 8.7 21 91.3 23 0.572
Age > 40 y.o 1 16.7 5 83.3 6 0.394
Nulli/Primipara 4 5.1 74 94.9 78 0.118
History of prior preeclampsia 1 33.3 2 66.7 3 0.219
History of hypertension in pregnancy
at their mothers or sisters
1 10 9 90 10 0.573
Gemelli delivery 0 0.0 2 100 2 0.849
Figure 1. Spreading of C-Reactive Protein Level at Vari-
ous Samples Study
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DISCUSSION
The results of this study showed that 115 samples
with second trimester of pregnancy whose CRP
levels were checked, as much as 9 subjects who
develop preeclampsia. Of the 9 patients who
develop preeclampsia, a total of 4 patients had
higher levels of C-reactive protein, which is
categorized as high ( 4.9 mg / l), 4 patients had
medium levels of C-reactive protein, which is
categorized as moderate (1.8 - 4.8 mg / l), and
there is one patient who had lower levels of
C-reactive protein (<1.8 mg / l).
Based on the study results, there is a tendency
of patients with preeclampsia had higher levels of
C-Reactive Protein. The mean of CRP in patients
suffering from preeclampsia is 5.05 mg / l. Of the
9 patients who suffer from preeclampsia, there
were two patients who do not have risk factors for
preeclampsia. Based on Fisher’s Exact test results
conducted between risk factors for preeclampsia
with the incidence of preeclampsia, there is not
found significantly the relationship between risk
factors and the incidence of preeclampsia. This
means that the risk factors that exist is not a
confounding factor in this study.
The incidence of preeclampsia varies; it is
affected by parity, race / ethnicity, genetic
predisposition, environment, socioeconomy and
other factors. It is reported that the incidence of
preeclampsia in nulliparous population ranges
from 3 to 10%. In this study, we found as many
as 23 subjects who did not have preeclampsia risk
factors, but there were 2 (8.7%) of them developed
into preeclampsia. It shows how a pregnancy can
trigger a state of hypertension remains a mystery
although more research is trying to solve it.3
Extremes of maternal age (under 20 years and
above 35 years) increases the risk of pre-
eclampsia.5 In this study, 30 subjects belongs in
the extreme age and two of them suffered from
preeclampsia. Data on demographic characteristics
conducted by Qiu et al (2004) reported that no
significant difference between preeclampsia and
control groups on the age of the subject.4 Duckitt
and Harrington (2005), report of 5 cohort study of
risk factors for preeclampsia, multipara with a
history of preeclampsia increases the risk until
seven-fold (RR 7.19 95% CI 5.85 to 8.83) on five
cohort studies.8 In this study, we found that
between 3 subjects who have risk factors multi-
para with a history of preeclampsia earlier, gained
1 (33.3%) subjects experienced preeclampsia.
Subjects with a history of preeclampsia in their
mother and sister of three-fold increase risk (RR
2.90 95% CI 1.49 to 8.67), and 10 cases obtained
1 (10%) incidence of preeclampsia, although not
statistically there is no significance result (p
<0.05).1,8 It is associated with genetic factors,
hereditary tendency due to the interaction of
hundreds of genes inherited from both father and
mother which controls a number of metabolic and
enzymatic functions in every organ, clinically
manifest in women who develop preeclampsia.3
According Gammill et al (2010), the role of CRP
is particularly interesting in the case of obesity,
because CRP is closely related to BMI and is also
directly affected by the endocrine function of
adipose tissue.9 Benyo et al (2001), shows that
there is no difference between the expression of
pro-inflammatory cytokines in the placenta of
women with preeclampsia compared with controls,
so we could say that the increase in inflammatory
markers in preeclampsia maternal derived from
non-placental source.10 The main CRP is produced
by hepatocytes, under the influence of interleukin-
6 (IL-6) and tumor necrosis factor-alpha (TNF-).
Both of pro-inflammatory cytokines are produced
by adipose tissue. Interestingly, IL-6 and TNF-
also increased in preeclampsia which is clinically
manifested.
The association between obesity and preeclamp-
sia has been investigated. In a study aiming to
Figure  2. The Difference between CRP Level of Pre-
eclampsia Group and non-Preeclampsia Group
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understand how the mechanisms by which obesity
predispose to preeclampsia, Bodnar et al (2005),
found that increased of inflammation (measured
by CRP), with a combination of hypertrigly-
ceridemia, covering about a third of the increase
in such risks.11 Never the less, in this study, BMI
measurement in the second trimester of pregnancy
can not be used as a source of data that can be
associated with CRP because the measurement
based on height and weight during pregnancy is
also associated with fetal weight, so they were
difficult to assess the real IMT, unlike the BMI
measurement before pregnancy or early in
pregnancy.
It has been proposed that CRP, in accordance
with its function, is able to elicite the inflammatory
response characteristic of preeclampsia.12 CRP is
increased in those with preeclampsia; however,
there is still debate regarding the potential utility
of CRP as an early marker for preeclampsia.13 Wolf
et al showed that elevated levels of CRP during the
first trimester in women suffering from preeclamp-
sia, where Savvidou et al (2002), showed that CRP
levels at the end of the second trimester was not
associated with preeclampsia.14,15
In this study of 115 subjects showed whom CRP
levels were examined in the second trimester of
pregnancy, 9 subjects with preeclampsia was 4 of
which have high levels of CRP, and there is one that
is low CRP levels but experienced preeclampsia. In
addition, of the 106 subjects who did not develop
preeclampsia, a total of 26 subjects have high levels
of CRP but did not develop preeclampsia. This
suggests that the increasing of CRP was not
significantly different with the incidence of
preeclampsia which was obtained p> 0.094.
CONCLUSIONS
In this study, there were 9 cases of preeclampsia
among 115 subjects studied, where there is a
tendency of increase in the incidence of pre-
eclampsia in pregnant women with risk factors
for age over 40 years, nulli / primiparity, previous
history of preeclampsia, and family history of
hypertensive disorder in pregnancy. CRP levels in
the preeclampsia group on average higher than
those not preeclampsia, but these results can not
be used as value for predicting preeclampsia.
Further research needs to be carried out by using
other parameters to determine the extent of
C-reactive protein is able to identify women at
high risk of developing preeclampsia.
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